Efficient, streamlined production workflows enable the delivery of high-titer rAAV typically within approximately two weeks from plasmid acceptance at SignaGen Laboratories. This accelerated timeline is achieved through parallelized upstream processing, optimized transfection and culture conditions, and rapid purification and quality control workflows without compromising vector quality. For time-sensitive projects, an expedited option can be arranged, in which packaging is initiated on Friday followed by early harvest on Monday, allowing rAAV production to be completed in as little as one week. This flexible scheduling ensures rapid turnaround for urgent studies while maintaining consistent yield, purity, and performance standards.